Interim Chair and CEO Gregory Adams said the late Bernard Tyson "spent his entire career focused on ensuring greater access to affordable, high-quality health care for all, and I know the school that now bears his name will help carry this legacy into the future," in today's bite-sized hospital and health industry news from California, Illinois, and Pennsylvania.
Johnson & Johnson's Janssen pharmaceutical subsidiary will launch the company's first solely digital trial, testing the use of its diabetes drug Invokana to treat a heart condition—and the move could have three major implications, write Advisory Board's Brandi Greenberg and Pam Divack.
While the flu shot is free for insured patients, this common health care service provides "a prime example" of how opaque health care pricing can cost patients in the long run, Phil Galewitz reports for Kaiser Health News.
Stephen Hahn, President Trump's nominee for FDA commissioner, on Wednesday faced questions from lawmakers on the Senate Health, Education, Labor and Pensions Committee regarding drug shortages and prices, e-cigarette use, and more.
In an ED, a gushing nosebleed like the one Jay Wellons, a pediatric neurosurgeon at Vanderbilt University Medical Center, encountered midflight would be treated with special glue and a microcatheter. Writing for the New York Times, Wellons describes how he and a nurse practitioner managed to "essentially" stop the hemorrhaging with everyday items.
CMS on its Nursing Home Compare website has begun indicating when nursing homes have been cited for abuse violations, and while the move has been applauded by consumer advocates, some in the nursing home industry say the alerts are misleading.
Members of a CMS advisory panel are worried that potential long-term changes to CMS' star ratings methodology won't actually help patients make informed decisions about where to go for care, Michael Brady reports for Modern Healthcare.